Raleigh Capital Management Inc. Vertex Pharmaceuticals Inc Transaction History
Raleigh Capital Management Inc.
- $253 Million
- Q4 2024
A detailed history of Raleigh Capital Management Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 236 shares of VRTX stock, worth $110,912. This represents 0.04% of its overall portfolio holdings.
Number of Shares
236
Previous 249
5.22%
Holding current value
$110,912
Previous $115,000
17.39%
% of portfolio
0.04%
Previous 0.05%
Shares
9 transactions
Others Institutions Holding VRTX
# of Institutions
1,717Shares Held
222MCall Options Held
1.65MPut Options Held
1.37M-
Capital World Investors Los Angeles, CA26.8MShares$12.6 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$10.9 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.55 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.23 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $121B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...